The Peninsula
DOHA: Clinicians and researchers from Hamad Medical Corporation (HMC) and other organisations in Qatar gathered recently to exchange research ideas and gain new knowledge at the third Research Forum.
Organised by HMC’s Medical Research Centre, the event is held regularly as part of efforts to foster a strong research culture and promote the development of high-quality research at HMC and in Qatar.
HMC researchers represented the majority of the 142 delegates, with additional attendees from Qatar University (QU), Sidra Medical and Research Center, Weill Cornell Medical College in Qatar and Hamad Bin Khalifa University.
The third meeting addressed current research on infectious diseases undertaken by researchers in HMC and affiliated biomedical institutes in Qatar.
Dr Abdullatif Al Khal, Senior Consultant and HMC’s Deputy Chief Medical Officer, welcomed the participants. Professor Ibrahim Janahi, HMC’s Executive Director of Research, said, “The forum provides a platform for those interested in research to exchange expertise and research knowledge and encourages collaborations among colleagues to strengthen our research capacity. Research is vital for achieving HMC’s vision for healthcare in Qatar. It enables the development of new and improved treatments and helps our healthcare teams deliver the safest, most effective and most compassionate care to our patients.”
Researchers from HMC and QU presented their studies. Research topics included streptococcus anginosus infections, H1N1 influenza (swine flu), candidiasis or yeast infections, hepatitis C, food-borne diseases, tuberculosis, pseudomonas aeruginosa (a multi-drug resistant pathogen that causes complicated and life-threatening infections) cystic fibrosis, and a study on increasing immunogenicity of influenza and human immunodeficiency virus vaccines.
Each assembly of the forum consists of two segments to guide researchers and share work across HMC. The first is ‘Bring your research’, a segment where the Research Support Committee provides advice and guidance for researchers on any aspect of clinical, public health, biomedical, molecular and basic science research. The committee comprises researchers and scientists from within HMC. Nineteen researchers received support for their ideas and projects from the committee. The second segment is ‘Present your research’ which provides opportunity for biomedicine researchers in Qatar to present ongoing or published research around the central clinical or research topic for each assembly, with the third assembly focusing on infectious disease.
The Peninsula
DOHA: Clinicians and researchers from Hamad Medical Corporation (HMC) and other organisations in Qatar gathered recently to exchange research ideas and gain new knowledge at the third Research Forum.
Organised by HMC’s Medical Research Centre, the event is held regularly as part of efforts to foster a strong research culture and promote the development of high-quality research at HMC and in Qatar.
HMC researchers represented the majority of the 142 delegates, with additional attendees from Qatar University (QU), Sidra Medical and Research Center, Weill Cornell Medical College in Qatar and Hamad Bin Khalifa University.
The third meeting addressed current research on infectious diseases undertaken by researchers in HMC and affiliated biomedical institutes in Qatar.
Dr Abdullatif Al Khal, Senior Consultant and HMC’s Deputy Chief Medical Officer, welcomed the participants. Professor Ibrahim Janahi, HMC’s Executive Director of Research, said, “The forum provides a platform for those interested in research to exchange expertise and research knowledge and encourages collaborations among colleagues to strengthen our research capacity. Research is vital for achieving HMC’s vision for healthcare in Qatar. It enables the development of new and improved treatments and helps our healthcare teams deliver the safest, most effective and most compassionate care to our patients.”
Researchers from HMC and QU presented their studies. Research topics included streptococcus anginosus infections, H1N1 influenza (swine flu), candidiasis or yeast infections, hepatitis C, food-borne diseases, tuberculosis, pseudomonas aeruginosa (a multi-drug resistant pathogen that causes complicated and life-threatening infections) cystic fibrosis, and a study on increasing immunogenicity of influenza and human immunodeficiency virus vaccines.
Each assembly of the forum consists of two segments to guide researchers and share work across HMC. The first is ‘Bring your research’, a segment where the Research Support Committee provides advice and guidance for researchers on any aspect of clinical, public health, biomedical, molecular and basic science research. The committee comprises researchers and scientists from within HMC. Nineteen researchers received support for their ideas and projects from the committee. The second segment is ‘Present your research’ which provides opportunity for biomedicine researchers in Qatar to present ongoing or published research around the central clinical or research topic for each assembly, with the third assembly focusing on infectious disease.
